MedTrace Logo

Intervention for Alcohol Use Disorder Recovery After Liver Transplantation

NCT07214259 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-10-24

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if it is feasible and acceptable to use a recovery coach and an online sober active community to help with alcohol use disorder after liver transplant. The main questions it aims to answer are:

* Is using a recovery coach after liver transplant to help with alcohol use recovery feasible and acceptable?
* Is using an online sober active community after liver transplant to help with alcohol use recovery feasible and acceptable? Researchers will compare standard of care including a recovery coach alone to a recovery coach plus to assist with recovery from alcohol use recovery after liver transplant

Participants will:

* Work with a recovery coach including a weekly phone call
* Visit the clinic once every 3 months for a checkup and to complete surveys
* If randomized to the intervention arm, download an online application with access to a digital sober active community

Conditions

  • Liver Transplant Recipient
  • Alcohol Use Disorders (AUD)

Interventions

BEHAVIORAL

Online Sober Active Community

Participants will have access to an online sober active community that they can use to augment their recovery process.

BEHAVIORAL

Recovery coach

Participants will work with a recovery coach including having weekly phone calls with that recovery coach.

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Leigh Anne Dageforde

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2027-12-31
Completion
2028-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07214259 on ClinicalTrials.gov